139 related articles for article (PubMed ID: 34449586)
1.
Metser U; Ortega C; Hussey D; Chan R; Berlin A; Finelli A; Veit-Haibach P
Curr Oncol; 2021 Aug; 28(5):3251-3258. PubMed ID: 34449586
[TBL] [Abstract][Full Text] [Related]
2. Patterns of disease detection using [
Koschel S; Taubman K; Sutherland T; Yap K; Chao M; Guerrieri M; Benson A; Starmans M; Byrne G; Ong G; Macleod C; Foo M; Wong LM; Gyomber D; Ng M
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3712-3722. PubMed ID: 33852051
[TBL] [Abstract][Full Text] [Related]
3. Effect of
Metser U; Zukotynski K; Mak V; Langer D; MacCrostie P; Finelli A; Kapoor A; Chin J; Lavallée L; Klotz LH; Hagerty M; Hildebrand C; Bauman G
Radiology; 2022 May; 303(2):414-422. PubMed ID: 35076300
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of
Song H; Harrison C; Duan H; Guja K; Hatami N; Franc BL; Moradi F; Aparici CM; Davidzon GA; Iagaru A
J Nucl Med; 2020 Apr; 61(4):546-551. PubMed ID: 31628216
[No Abstract] [Full Text] [Related]
5. [
Oprea-Lager DE; Gontier E; García-Cañamaque L; Gauthé M; Olivier P; Mitjavila M; Tamayo P; Robin P; García Vicente AM; Bouyeure AC; Bailliez A; Rodríguez-Fernández A; Mahmoud SB; Vallejo-Casas JA; Maksud P; Merlin C; Blanc-Durand P; Drouet C; Tissot H; Vierasu I; Vander Borght T; Boos E; Chossat F; Hodolic M; Rousseau C
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3439-3451. PubMed ID: 37341747
[TBL] [Abstract][Full Text] [Related]
6. Predictors of
Mena E; Rowe SP; Shih JH; Lindenberg L; Turkbey B; Fourquet A; Lin FI; Adler S; Eclarinal P; McKinney YL; Citrin DE; Dahut W; Wood BJ; Chang R; Levy E; Merino M; Gorin MA; Pomper MG; Pinto PA; Eary JF; Choyke PL; Pienta KJ
J Nucl Med; 2022 Aug; 63(8):1184-1190. PubMed ID: 34916246
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
[TBL] [Abstract][Full Text] [Related]
9. Early lesion detection with
Wondergem M; Jansen BHE; van der Zant FM; van der Sluis TM; Knol RJJ; van Kalmthout LWM; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1911-1918. PubMed ID: 31230088
[TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of PSMA-Targeted
Rowe SP; Campbell SP; Mana-Ay M; Szabo Z; Allaf ME; Pienta KJ; Pomper MG; Ross AE; Gorin MA
J Nucl Med; 2020 Jan; 61(1):58-61. PubMed ID: 31201249
[TBL] [Abstract][Full Text] [Related]
11. [
Glicksman RM; Metser U; Valliant J; Chung PW; Fleshner NE; Bristow RG; Green D; Finelli A; Hamilton R; Stanescu T; Hussey D; Catton C; Gospodarowicz M; Warde P; Bayley A; Breen S; Vines D; Jaffray DA; Berlin A
BMJ Open; 2020 Apr; 10(4):e035959. PubMed ID: 32327479
[TBL] [Abstract][Full Text] [Related]
12.
Ceci F; Castellucci P; Graziani T; Farolfi A; Fonti C; Lodi F; Fanti S
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):31-39. PubMed ID: 30350010
[TBL] [Abstract][Full Text] [Related]
13. Treatment Outcomes from
Emmett L; van Leeuwen PJ; Nandurkar R; Scheltema MJ; Cusick T; Hruby G; Kneebone A; Eade T; Fogarty G; Jagavkar R; Nguyen Q; Ho B; Joshua AM; Stricker P
J Nucl Med; 2017 Dec; 58(12):1972-1976. PubMed ID: 28747524
[No Abstract] [Full Text] [Related]
14. 3-Year Freedom from Progression After
Emmett L; Tang R; Nandurkar R; Hruby G; Roach P; Watts JA; Cusick T; Kneebone A; Ho B; Chan L; van Leeuwen PJ; Scheltema MJ; Nguyen A; Yin C; Scott A; Tang C; McCarthy M; Fullard K; Roberts M; Francis R; Stricker P
J Nucl Med; 2020 Jun; 61(6):866-872. PubMed ID: 31676727
[No Abstract] [Full Text] [Related]
15. Interobserver variability, detection rate, and lesion patterns of
Miksch J; Bottke D; Krohn T; Thamm R; Bartkowiak D; Solbach C; Bolenz C; Beer M; Wiegel T; Beer AJ; Prasad V
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2339-2347. PubMed ID: 32157427
[TBL] [Abstract][Full Text] [Related]
16.
Farolfi A; Ceci F; Castellucci P; Graziani T; Siepe G; Lambertini A; Schiavina R; Lodi F; Morganti AG; Fanti S
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):11-19. PubMed ID: 29905907
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, Predictive Factors, and Prediction Nomograms for
Rauscher I; Düwel C; Haller B; Rischpler C; Heck MM; Gschwend JE; Schwaiger M; Maurer T; Eiber M
Eur Urol; 2018 May; 73(5):656-661. PubMed ID: 29358059
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of
Morris MJ; Rowe SP; Gorin MA; Saperstein L; Pouliot F; Josephson D; Wong JYC; Pantel AR; Cho SY; Gage KL; Piert M; Iagaru A; Pollard JH; Wong V; Jensen J; Lin T; Stambler N; Carroll PR; Siegel BA;
Clin Cancer Res; 2021 Jul; 27(13):3674-3682. PubMed ID: 33622706
[TBL] [Abstract][Full Text] [Related]
19. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY
Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322
[TBL] [Abstract][Full Text] [Related]
20. Detection Efficacy of
Giesel FL; Knorr K; Spohn F; Will L; Maurer T; Flechsig P; Neels O; Schiller K; Amaral H; Weber WA; Haberkorn U; Schwaiger M; Kratochwil C; Choyke P; Kramer V; Kopka K; Eiber M
J Nucl Med; 2019 Mar; 60(3):362-368. PubMed ID: 30042163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
